Fri 23 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| A Compartive Multicenter Study of Neoadjuvant Docetaxel/Cisplatin Followed by Concurrent Cisplatin with Radiotherapy using Intensity-Modulated Radition Therapy (IMRT) with or without Bevacizumab for Locally Advanced Nasopharyngeal Cancer | King Fahad Medical City | Terminated | Docetaxel/Cisplatin and Bevacizumab | 3 | Version 1.3 date 6 may 2012 | King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh) |
| "An open-label extension study of the long-term safety,tolerability and efficacy of Ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension(CTEPH)." | GSK | Terminated | Ambrisentan | 3 | 116457 | King Fahad Medical City (Riyadh) |
| Efficacy of lntra-cervical Misoprostol in the Management of Early Pregnancy Failure: Randumized Clinical Trial | King Abdulaziz University Hospital | Rejected | Misoprostol | 2 | 227-15 | King Abdulaziz University Hospital (Jeddah) |
| "A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus" | MSD | Terminated | MK-0431A (Sitagliptin / Metformin) vs Liraglutide | 3 | MK-0431A-180-00 | King Khalid University Hospital (Riyadh) |
| "Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients" | Astellas | Completed | • Micafungin• Fluconazole• Liposomal Amphotericin B• Caspofungin | 3b | 9463EC0001 | King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh) |
| An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients | Alcon | Completed | Travoprost 0.004% | 1 | C-12-009 | King Khaled Eye Specialist Hospital (Riyadh) |
| A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease. | Eli Lilly | Terminated | Prasugrel | 3 | H7T-MC-TADO | King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh) |
| A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) | Merck Serono | Terminated | Lutropin alfa | 3b | EMR200061_506 | King Abdulaziz University Hospital (Jeddah) |
| SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety | SPIMACO | Terminated | Fastulin R / Normulin N | 3 | (version 1.4) Aug 2011 | King Fahad Medical City (Riyadh) |
| "A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes " | Sanofi | Terminated | GLIMEPIRIDE-HOE490 | 3 | GLIME_R_05809 | King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh) |
Last update date: 06/10/2026 at 08:14 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.